T-cell agonists in cancer immunotherapy Y Choi, Y Shi, CL Haymaker, A Naing, G Ciliberto, J Hajjar Journal for immunotherapy of cancer 8 (2), 2020 | 112 | 2020 |
Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer Y Choi, JW Kim, KH Nam, SH Han, JW Kim, SH Ahn, DJ Park, KW Lee, ... Gastric Cancer 20, 602-611, 2017 | 108 | 2017 |
Bevacizumab plus erlotinib combination therapy for advanced hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma: a multicenter retrospective … Y Choi, B Keam, M Kim, S Yoon, D Kim, JG Choi, JY Seo, I Park, JL Lee Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2019 | 57 | 2019 |
Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards Y Choi, JW Kim, KJ Suh, YJ Lim, JY Lee, BD Kang, JW Kim, SH Kim, ... BMC Palliative Care 18, 1-8, 2019 | 4 | 2019 |
Successful management of severe allergic reactions to platelet transfusion with omalizumab: A case report Y Choi, JM Byun, I Kim, JH Park, KH Kim, JS Kim, IS Choi, MS Yang, ... Medicine 100 (44), e27724, 2021 | 3 | 2021 |
Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors SA Kim, J Lee, JH Moon, H Lee, J Jang, JW Cheong, J Youk, Y Choi, ... Annals of Hematology 98, 501-510, 2019 | 2 | 2019 |
8 Immune correlates associated with clinical outcomes in patients with advanced malignancies treated with avelumab and OX40 agonist A Naing, D Karp, S Piha-Paul, C Haymaker, E Parra, F Yang, S Pant, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
Outcome of Disseminated Intravascular Coagulation without Documented Antiphospholipid Antibody Successfully Treated with Rituximab H Park, J Youk, S Cho, JH Lee, Y Choi, Y Koh Soonchunhyang Medical Science 21 (2), 154-158, 2015 | 1 | 2015 |
Use of Immunoglobulin Replacement Therapy in Clinical Practice: A Review J Ahmed, Y Choi, T Ko, JA Lim, J Hajjar Journal of Immunotherapy and Precision Oncology 8 (1), 34-46, 2025 | | 2025 |
Advances in CAR T Cell Therapy: Antigen Selection, Modifications, and Current Trials for Solid Tumors SH Khan, Y Choi, M Veena, JK Lee, DS Shin Frontiers in Immunology 15, 1489827, 2025 | | 2025 |
Abstract PO1-13-07: LIV-1 and Trop2 expression using Immunohistochemistry as prognostic markers in early breast cancer Y Choi, HS Ryu, J Koh, DW Lee, K Lee, SA Im Cancer Research 84 (9_Supplement), PO1-13-07-PO1-13-07, 2024 | | 2024 |
Guest Editor and Reviewer Acknowledgments: 2020 M Basik, MA Bilen, H Chen, J Hajjar, AR Jazieh, H Loong, C Massard, ... Journal of Immunotherapy 3 (4), 175, 2020 | | 2020 |
The landscape of the tumor-infiltrating B cell and its association with T-cell and tumor microenvironment in human cancers. YK Chae, WH Bae, Y Choi, YS Kim, JF Anker, FJ Giles Journal of Clinical Oncology 35 (7_suppl), 76-76, 2017 | | 2017 |
The impact of matched vs. mismatched nationality among donor and recipients in allogeneic stem cell transplantation: A retrospective multi-institutional study in Korea J Youk, Y Choi, SJ Shin, J Lee, M Shin, J Shin, R Kim, Y Koh, I Kim, ... BONE MARROW TRANSPLANTATION 51, S144-S145, 2016 | | 2016 |
Comparing treatment outcome of allogeneic stem cell transplantation according to the stem cell source: How to manage if donor from Korean Marrow Donor Program is unavailable? Y Choi, R Kim, H Park, J Youk, Y Koh, I Kim, S Park, SS Yoon BONE MARROW TRANSPLANTATION 50, S370-S370, 2015 | | 2015 |
Cardiopulmonary Resuscitation in cancer patients-Is it really necessary and unavoida ble? Y Choi, B Kang, S Kim, YJ Kim, JH Kim, JS Lee 대한내과학회 추계학술발표논문집 2015 (1), 247-247, 2015 | | 2015 |